颅内顺应性的波形衍生指标:验证与搏动动力学
该研究分析了96例同步ICP和TCD高分辨率记录中的4388个5分钟片段,评估脉冲形状指数(PSI)与潮波(P2)/冲击波(P1)比值的关联。PSI与P2/P1强相关(r≈0.74-0.76),对顺应性受损(P2/P1>1.1)的判别AUC约0.93。RAP和CI与P2/P1的关联弱且个体差异大。低振幅(<1.5 mm Hg)但波形顺应性受损的表型与较低RAP相关。结论支持波形自动评估顺应性,但形态学 alone 不足,需结合振幅和储备指数。
要点
- PSI与P2/P1强相关(r≈0.74-0.76),对顺应性受损(P2/P1>1.1)判别AUC≈0.93,支持自动化波形评估。
- RAP和CI与P2/P1的群体关联弱且个体差异大,单独使用不可靠。
- 低脉冲振幅(<1.5 mm Hg)但波形顺应性受损的表型与较低RAP相关,提示需关注振幅。
- 形态学指标 alone 不足,加入振幅可改善模型拟合和分类性能,支持多参数颅内监测。
适用人群与场景
- 纳入96例同步高分辨率ICP和TCD脑血流速度记录,共4388个非重叠5分钟片段;具体纳入/排除标准原文未提及。
- 适用场景为需要颅内压监测和顺应性评估的神经重症患者,原文未明确急诊/ICU/院前具体场景。
诊断标准与关键阈值
- 顺应性受损定义为P2/P1 > 1.1,顺应性保留定义为P2/P1 < 0.9(原文标准)。
- PSI和P2/P1从归一化ICP脉冲中衍生;脉冲振幅(AMP)、RAP、TCD衍生的动脉顺应性(CA)和颅内顺应性(CI)按片段计算。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 研究类型为回顾性分析(基于高分辨率记录),样本量96例记录、4388个5分钟片段,单中心(原文未明确中心数)。
- PSI与P2/P1在片段、记录和患者水平均强相关(r≈0.74-0.76),对顺应性受损(P2/P1>1.1)的判别AUC≈0.93。
- RAP和CI与P2/P1的群体水平关联弱且不一致,个体间变异大;CA和CI增量解释价值有限。
- 低AMP(<1.5 mm Hg)但波形顺应性受损的表型与较低RAP相关;纳入AMP改善模型拟合和分类性能,超越单纯形态学指标。
证据类型、等级与局限
- 证据类型为回顾性观察性研究(基于同步ICP和TCD记录的分析),原文未给出证据等级或推荐强度。
- 局限:原文未明确提及;设计上为单中心(原文未明确)、样本量有限(96例记录)、回顾性分析、未提供前瞻性验证。
对床旁实践的改变
- 支持使用PSI自动化评估颅内顺应性,但不能仅依赖形态学指标;应结合脉冲振幅(AMP)和RAP等多参数信息。
- 低AMP(<1.5 mm Hg)可能掩盖波形顺应性受损,需警惕单纯形态学评估的陷阱。
- 原文未提及具体适用与不适用人群的排除标准,临床决策需结合个体情况。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Visual interpretation of intracranial pressure (ICP) waveforms is widely used to assess intracranial compliance but lacks rigorous validation. We evaluated the pulse shape index (PSI) against the tidal wave (P2)/percussion wave (P1) ratio and examined the contributions of pulse amplitude, compensatory reserve [pressure-volume compensatory reserve index (RAP)] and transcranial Doppler (TCD)-derived indices.
METHODS: A total of 4388 non-overlapping 5-min segments from 96 high-resolution recordings of simultaneous ICP and TCD blood velocity were analysed. PSI and P2/P1 were derived from normalised ICP pulses. ICP pulse amplitude (AMP), RAP and TCD-derived arterial and intracranial compliance indices [arterial compliance (CA), intracranial compliance (CI)] were calculated per segment. Associations were assessed at segment, recording, and patient levels using correlation and mixed-effects models. Discriminatory performance for impaired (P2/P1 > 1.1) and preserved (P2/P1 < 0.9) compliance was evaluated using receiver operating characteristic (ROC) and precision-recall analyses. Concordance between PSI and P2/P1 classifications was assessed using Chi-squared threshold mapping.
RESULTS: PSI demonstrated a strong association with P2/P1 (r ≈ 0.74-0.76 across analysis levels) and high discrimination for impaired compliance [area under the curve (AUC) ≈ 0.93]. RAP and CI showed weak and inconsistent population-level associations with P2/P1, with substantial inter-individual variability. A distinct phenotype of low AMP (< 1.5 mm Hg) despite impaired waveform-derived compliance was associated with lower RAP. CA and CI provided limited incremental explanatory value, whereas inclusion of AMP improved model fit and classification performance beyond morphology-based metrics alone.
CONCLUSIONS: PSI closely reflects P2/P1 and supports automated waveform-based compliance assessment. However, morphology alone is insufficient; amplitude and reserve indices provide complementary information, supporting a multiparametric approach to intracranial monitoring.
参考来源
- Olakorede I, Bögli SY, Czosnyka M, et al. Waveform-Derived Metrics of Intracranial Compliance: Validation and Pulsatile Dynamics. Neurocrit Care. 2026. PMID: 42547674. doi:10.1007/s12028-026-02620-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。